|Medtronic Named a World Leader in Sustainability|
MINNEAPOLIS – Sept. 13, 2012 – Medtronic, Inc. (NYSE: MDT) today was named one of the world’s leading sustainability companies by its inclusion in the Dow Jones Sustainability World Index (DJSI World) and the FTSE4Good Index Series. The DJSI list, released today, analyzes companies on a series of sustainability criteria, including economic performance, environmental stewardship and social responsibility.
“We are proud of our efforts to address chronic disease, to follow environmentally sound business practices, and to bring sustainable value to all of our stakeholders,” said Omar Ishrak, Medtronic chairman and CEO. “We are pleased to be recognized for these efforts by our inclusion on the DJSI World list.”
One example of Medtronic’s sustainability commitment is the ongoing effort to bring life-saving therapies to millions of patients in emerging markets, who don’t currently have access to such technologies. In August of 2012, Medtronic announced the opening of a research and development center in Shanghai, China, the company’s first outside the United States and Europe. The Shanghai Innovation Center will work closely with local universities, research institutes, and physicians in China to create innovative, cost-effective strategies to serve patients in that country. Medtronic intends to hire and train 1,000 skilled staff over the next five years, who will focus on developing new medical technologies within the Innovation Center.
The Dow Jones Sustainability Index tracks the financial performance of the world’s leading sustainability-driven companies. The DJSI World list, which listed Medtronic for the second year in a row, represents the top 10 percent of the largest 2,500 companies in the Dow Jones Global Total Stock Market. More information about the DJSI can be found at http://www.sustainability-indexes.com.
The FTSE4Good Index Series measures the performance of companies that meet globally recognized corporate responsibility standards and facilitates investment in those companies. It is calculated by the global index provider FTSE Group. For more information about the FTSE4Good Index Series, visit http://www.ftse.com/ftse4good.
Any forward looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
-end-Medtronic Media Contacts:
Cindy Resman, Public Relations, 763-505-0291
Jeff Warren, Investor Relations, 763-505-2696